Skip to content

Incidence increasing of HIV-associated multicentric Castleman's disease, a relatively rare lymphatic cancer

Rapid progression of liver fibrosis in HIV-positive gay men recently infected with hepatitis C

Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries

Long-term HIV treatment cuts risk of hardening of coronary artery

Next generation first-line NNRTI, rilpivirine (TMC278) potent; lowest dose better-tolerated than efavirenz at 96 weeks

Do not use HIV tests bought over the internet, warns UK medicines regulators

`Express care` by nurses for people starting HIV treatment decreases clinic congestion, and may improve outcomes

Will male circumcision protect women, ask advocates?

HSV-2 suppression with aciclovir and HIV transmission: further conflicting data from randomised studies